Nuvation Bio Inc

General ticker "NUVB" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $759.4M

Nuvation Bio Inc follows the US Stock Market performance with the rate: 35.4%.

Estimated limits based on current volatility of 4.2%: low 2.58$, high 2.80$

Factors to consider:

  • Current price 25.7% above estimated high
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.87$, 2.12$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.08$, 2.44$]

Financial Metrics affecting the NUVB estimates:

  • Negative: Non-GAAP EPS, $ of -0.33 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -18.55 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term NUVB quotes

Long-term NUVB plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $93.32MM $119.73MM $99.82MM
Operating Income $-93.32MM $-119.73MM $-99.82MM
Non-Operating Income $6.47MM $15.54MM $24.02MM
R&D Expense $69.04MM $87.81MM $71.29MM
Income(Loss) $-86.85MM $-104.20MM $-75.80MM
Profit(Loss) $-86.85MM $-104.20MM $-75.80MM
Stockholders Equity $746.00MM $655.08MM $605.12MM
Assets $776.15MM $672.14MM $621.48MM
Operating Cash Flow $-68.19MM $-96.11MM $-68.00MM
Capital expenditure $0.28MM $0.37MM $0.07MM
Investing Cash Flow $-454.67MM $63.46MM $8.92MM
Financing Cash Flow $625.53MM $1.33MM $0.63MM
Earnings Per Share* $-0.40 $-0.41 $-0.35

* EPS are Split Adjusted, recent splits may be reflected with a delay.